查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1475016

全球藥品包裝材料市場評估：依包裝類型、依原料、依藥物輸送、依最終用戶、依地區、機會、預測（2017-2031）

Pharma Packaging Materials Market Assessment, By Packaging Type, By Raw Material, By Drug Delivery, By End-user, By Region, Opportunities and Forecast, 2017-2031F
出版日期: | 出版商: Market Xcel - Markets and Data | 英文 233 Pages | 商品交期: 3-5個工作天內

價格

全球醫藥包裝材料市場規模預計將從 2023 年的 1,216.1 億美元增至 2031 年的 2,616.3 億美元，預計 2024-2031 年期間複合年增長率為 10.1%。 市場的成長可歸因於製藥業的擴張和醫療產業支出的增加。

藥品和藥品需求的不斷增長是加強藥品包裝材料需求的主要因素。 例如，根據美國疾病管制與預防中心在 2023 年 11 月審查的估計，大約 71.9% 的就診涉及藥物治療，大約開出了 10 億種藥物。 常用的處方藥物包括維生素、止痛藥和降血脂藥。 這些不斷增長的需求正在推動對藥品包裝材料的需求。 FDA等各種監管機構對藥品包裝的收緊加強了對藥品包裝材料的投資，從而對市場擴張產生了積極影響。

日益增長的環境問題已將重點放在開發可持續藥品包裝材料上，以支持市場擴張。 各製造商擴大開發技術上可回收的藥品包裝材料也進一步推動了市場的成長。

例如，難以回收廢棄物回收和再利用領域的全球領導者 TerraCycle 已將Honeywell的 Aclar 阻隔薄膜泡罩認證為技術上可回收的 PETG 和 PVC 泡罩。 該薄膜是我們生命科學產品組合的一部分，透過提供防潮保護來幫助保護藥物，以確保穩定性並保持藥物功效。 這些成就催生了回收醫藥泡罩包裝等多層材料的方法，支持了市場的擴張。

醫療和製藥業的擴張推動市場成長

製藥和醫療領域投資的增加，以及製造流程和技術創新的進步，正在為市場創造利潤豐厚的成長機會。 例如，投資印度公司估計，到 2027 財年，印度醫院部門的收入將達到 2,192 億美元。 這一增長預計將增加對藥品包裝材料的需求並擴大市場。

醫療保健行業的成長可歸因於大公司投資的增加、對醫療保健系統提供的各種福利的認識提高、收入水平的提高以及對醫療保健的重視。 這種增長增加了藥品的使用以及對藥品包裝材料的需求。 各種疾病和病症的流行對藥品和藥品，特別是藥品供應提出了進一步的需求，促使對藥品包裝材料的需求增加。 這些因素對市場成長做出了重大貢獻。

專注於永續藥品包裝開發為市場提供利潤豐厚的成長機會

世界各地的各種製藥和醫療公司正在開發全面的永續包裝計劃，以減少碳足跡並減少整個包裝供應鏈對塑膠的依賴。 由於環保意識不斷增強，消費者對環保包裝產品的需求不斷增加，進一步鼓勵製藥公司採用永續包裝解決方案，為消費者提供環保替代方案。 為了滿足對永續包裝解決方案日益增長的需求，各領先製藥公司正在加大對合作夥伴的投資，以減少包裝對環境造成的負面影響。 此類合作夥伴關係和舉措正在市場上創造利潤豐厚的成長機會。

此外，由於日益關注的環境問題，醫療器材和藥品包裝的主要供應商正在加大努力，確保開發由 100% 再生塑膠製成的藥瓶。 例如，2024 年 1 月，領先的清潔技術公司 Loop Industries, Inc. 和國際醫療器材和藥品包裝供應商 Bormioli Pharma 將推出 100% 回收的、品質如新的 Loop PET 樹脂。 這種高品質的替代藥品包裝正在為製藥業的可持續包裝制定新標準，並推動此類解決方案的開發投資，支持市場擴張。

本報告研究和分析了全球醫藥包裝材料市場，提供市場規模和預測、市場動態以及主要參與者的現狀和前景。

目錄

第一章研究方法

第 2 章專案範圍與定義

第 3 章執行摘要

第 4 章顧客回饋

  • 市場認知度與產品訊息
  • 品牌知名度與忠誠度
  • 購買決策時考慮的因素
  • 購買頻率
  • 購買介質

第五章全球藥包材市場展望（2017-2031）

  • 市場規模與預測
    • 金額
    • 數量
  • 依包裝類型
    • 小學
    • 中學
    • 第三
  • 依原料分類
    • 塑料
    • 金屬
    • 玻璃
    • 紙、紙板
    • 其他
  • 透過藥物輸送
    • 口腔醫學
    • 外用藥
    • 注射藥品
    • 肺
    • 鼻腔
    • 眼科
    • 靜脈注射用藥
    • 透皮
    • 其他
  • 依最終用戶
    • 藥品製造
    • 零售藥局
    • 合約包裝
    • 設施藥房
  • 依地區
    • 北美
    • 南美洲
    • 歐洲
    • 亞太地區
    • 中東/非洲
  • 市佔率：依公司劃分（2023 年）

第六章全球藥品包裝材料市場展望：依地區（2017-2031）

  • 北美
    • 市場規模與預測
    • 依包裝類型
    • 依原料分類
    • 透過藥物輸送
    • 依最終用戶
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 法國
    • 義大利
    • 英國
    • 俄羅斯
    • 荷蘭
    • 西班牙
    • 土耳其
    • 波蘭
  • 亞太地區
    • 印度
    • 中國
    • 日本
    • 澳大利亞
    • 越南
    • 韓國
    • 印尼
    • 菲律賓
  • 南美洲
    • 巴西
    • 阿根廷
  • 中東/非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第七章供給面分析

  • 生產能力：依公司劃分
  • 生產：依公司劃分
  • 營運效率：依公司劃分
  • 主要工廠地點（最多 25 個地點）

第 8 章市場地圖（2023 年）

  • 依包裝類型
  • 依原料分類
  • 透過藥物輸送
  • 依最終用戶
  • 依地區

第九章宏觀環境與產業結構

  • 需求與供給分析
  • 進出口分析
  • 供應鏈分析
  • PESTEL 分析
  • 波特五力分析

第 10 章市場動態

  • 生長促進因素
  • 抑製成長的因素（問題、限制因素）

第十一章主要公司狀況

  • 前 5 名市場領導者的競爭矩陣
  • 前 5 位市場領導者的市場收入分析（2023 年）
  • 併購/合資企業（如果適用）
  • SWOT 分析（5 家市場公司）
  • 專利分析（如果適用）

第十二章價格分析

第 13 章案例研究

第14章主要公司展望

  • Amcor plc
  • Berry Global Group, Inc.
  • Gerresheimer AG
  • Schott AG
  • AptarGroup Inc.
  • Catalent, Inc.
  • WestRock Company
  • Becton, Dickinson, and Company
  • Nipro Corporation
  • CCL Industries Inc.

第 15 章策略建議

第十六章關於我們公司，免責聲明

Product Code: MX11283

Global pharma packaging materials market is projected to witness a CAGR of 10.1% during the forecast period 2024-2031, growing from USD 121.61 billion in 2023 to USD 261.63 billion in 2031F. The growth of the market can be attributed to the expansion of the pharmaceutical sector and the increase in expenditure in the healthcare sector.

The rising requirement for drugs and medication is a major factor bolstering the requirement for pharma packaging materials. For instance, according to the estimates of Center for Disease Control and Prevention reviewed in November 2023, approximately 71.9% of physician office visits involve drug therapy and around 1 billion drugs are prescribed. The frequently prescribed classes of therapeutics include vitamins, analgesics, and antihyperlipidemic agents. The increased requirement is thus bolstering the demand for pharma packaging materials. The growing strictness of different regulatory bodies, such as FDA, towards pharmaceutical packaging is bolstering investments in pharma packaging materials, which in turn is positively influencing the global pharma packaging materials market expansion.

The increasing emphasis on the development of sustainable pharmaceutical packaging materials owing to rising environmental concerns is supporting the market's expansion. The augmenting efforts of various manufacturing companies to develop pharmaceutical packaging materials with technical recyclability further boost the market growth.

For instance, TerraCycle, a global leader in collecting and repurposing hard to recycle waste recognized Honeywell's Aclar Barrier Film Blisters as technically recyclable for PETG and PVC-based blisters. The film is a part of their Life Sciences portfolio and aids in protecting the drugs by providing moisture barrier protection to preserve the efficacy of the medicines and ensure the stability of the drug. Such achievements are supporting the expansion of the market as they provide methodologies for recycling multi-layer materials such as pharmaceutical blister packaging.

Expansion of Healthcare and Pharmaceutical Sectors Boosts Global Pharma Packaging Materials Market Growth

The increasing investments in the pharmaceutical and healthcare sector, along with advancements in manufacturing processes and technological innovations, provide lucrative growth opportunities to the market. For instance, Invest India estimated that the hospital sector in India will reach USD 219.2 billion (INR 18,348.78 billion) in revenue by the financial year 2027. The growth is expected to bolster the requirement for pharmaceutical packaging materials, supporting the expansion of the market.

The growth of the healthcare sector can be attributed to the rising investments by leading companies, increasing awareness about various benefits offered by the healthcare systems, rising income levels, and growing emphasis on health management. Due to the growth, the utilization of pharmaceutical products is augmenting, bolstering the demand for pharma packaging materials. The rising prevalence of various diseases and disorders further boosts the requirement for drugs and medications, among other pharmaceutical supplies, resulting in an increased demand for pharma packaging materials. These factors are heavily contributing to the growth of the market.

Increasing Emphasis on Development of Sustainable Pharma Packaging Provides Lucrative Growth Opportunities to the Market

Various pharmaceutical and healthcare companies across the globe are developing comprehensive sustainability packaging programs to reduce their carbon footprint and decrease their reliance on plastic across the packaging supply chain. Increased consumer demand for environment-friendly packaging products, owing to rising environmental consciousness, is further encouraging pharmaceutical companies to adopt sustainable packaging solutions and provide eco-friendly alternatives to consumers. To meet the increase in demand for sustainable packaging solutions, various leading pharmaceutical companies have boosted their investments in collaborations to reduce the negative environmental impact caused by their packaging. Such collaborations and efforts are providing lucrative growth opportunities to the market.

Moreover, due to growing concerns about the environment, leading providers of medical devices and pharmaceutical packaging are boosting their efforts to ensure the development of pharmaceutical bottles with 100% recycled plastic. For instance, in January 2024, Loop Industries, Inc., a leading clean technology company and Bormioli Pharma, an international provider of medical devices and pharmaceutical packaging, launched pharma packaging bottles that were developed using 100% recycled virgin-quality Loop PET resin. Such high-quality pharma packaging alternatives are aiding in establishing new standards for sustainable packaging in the pharmaceutical sector and bolstering investments towards developing such solutions, thus supporting the expansion of the market.

Asia-Pacific Accounts for Significant Market Share

The growth of the Asia-Pacific market can be attributed to the strong presence of key market players, the rapid expansion of the pharmaceutical sector, and increasing investments in the healthcare sector. The demand for pharma packaging materials is rising due to the increased requirement for different pharmaceutical products owing to rapid population growth. The increase in research and development activities in the pharmaceutical sector, coupled with the production of novel medications, is further bolstering the demand for pharma packaging materials in Asia-Pacific.

Additionally, the rapid expansion of the pharmaceutical sector supports market growth. For instance, Invest India estimates that the pharmaceutical market in the country will reach USD 130 billion by 2030. Moreover, India exports pharmaceutical products to over 200 countries, supplying approx. 25% of all medicines in the United Kingdom, around 40% of generic demand in the United States, and over 50% of Africa's requirement for generics. Additionally, 70% of WHOs vaccines are sourced from India. Thus, due to the growth in the requirement and export of different pharmaceutical products, the demand for pharma packaging materials is rising, boosting the market's growth.

Technological Advancements in Primary Packaging Aid Market Expansion

The increasing integration of radiofrequency identification in various packaging, such as prefilled syringes coupled with increased efforts towards development of counterfeit prevention mechanisms are supporting the growth of the market. For instance, the developments in printing techniques and 3D visualization are aiding in pushing the design boundaries of primary as well as secondary packaging, allowing companies to save time and money in development costs and material wastage. Such advancements will positively influence the growth of the market over the forecast period. Additionally, using primary packaging provides a compatible and safe barrier for medications. Due to it, the efforts to enhance the development of primary packaging are increasing, supporting the segment's expansion.

Pharmaceutical Manufacturing Will Boost Market Demand

The rising requirement for pharma packaging materials by the pharmaceutical manufacturing sector can be attributed to the increased demand for medications due to the expansion of the geriatric population and the growing prevalence of various diseases and disorders. According to WHO, by 2030, one in six individuals across the globe will be aged 60 or above, and by 2050, approximately 2.1 billion individuals will be 60 or older. The expansion of the geriatric population will bolster the demand for various pharmaceutical products as they are more prone to illnesses, propelling the requirement for pharma packaging materials and augmenting the growth of the market.

Additionally, the rapid expansion of pharmaceutical industry in various regions is further aiding the expansion of the market. For instance, the European Federation of Pharmaceutical Industries and Associations estimates that North America accounted for 49.1% of global pharmaceutical sales, while Europe accounted for 23.4%. Due to the rise in sales of pharmaceuticals, the demand for pharma packaging materials is rising, positively influencing the growth of the market.

Future Market Scenario (2024 - 2031F)

According to global pharma packaging materials market analysis, the market will witness significant growth over the forecast period owing to growing potential of automation, artificial intelligence, and blockchain technology for optimizing the traceability of finished products and streamlining the pharmaceutical packaging process. The requirement for intelligent packaging processes along with multiple packaging formats will witness an increase.

Furthermore, the utilization of pre-filled syringes and single-use vials that have the ability to accommodate a wider range of formulations and dosages and smaller volumes of medication will rise. The direct delivery of personalized treatment solutions to the patients will boost the demand for packaging materials that will protect the medications against various environmental factors. Thus, boosting the growth of the market and supporting the market expansion.

Additionally, due to the increasing emphasis on sustainability and burgeoning environmental crisis, various leading market players are actively investing towards the development of eco-friendly and biodegradable pharma packaging materials. Thus, providing lucrative growth opportunities to the market.

Key Players Landscape and Outlook

The increasing development of sustainable pharmaceutical packaging solutions will boost the growth of the market. For instance, high-barrier PVDC coating provided by Solvay provides an ultra-high water vapor barrier. It enables thin thermoforming films, aiding the pharma packaging material manufacturers to reduce their carbon footprint. The Diofan Ultra736's robust barrier properties allow for reduced coating thickness, with no negative effects on the performance of the package. The product contains no fluorine, allowing it to meet the regulatory requirements for direct pharmaceutical contact. Such product developments will aid the pharma packaging materials manufacturers in reducing their carbon footprint, positively influencing the growth of the market.

Table of Contents

1.Research Methodology

2.Project Scope & Definitions

3.Executive Summary

4.Voice of Customer

  • 4.1.Market Awareness and Product Information
  • 4.2.Brand Awareness and Loyalty
  • 4.3.Factors Considered in Purchase Decision
    • 4.3.1.Brand Name
    • 4.3.2.Quality
    • 4.3.3.Quantity
    • 4.3.4.Price
    • 4.3.5.Product Specification
    • 4.3.6.Form Specification
    • 4.3.7.Shelf Life
    • 4.3.8.Availability of Product
  • 4.4.Frequency of Purchase
  • 4.5.Medium of Purchase

5.Global Pharma Packaging Materials Market Outlook, 2017-2031F

  • 5.1.Market Size & Forecast
    • 5.1.1.By Value
    • 5.1.2.By Volume
  • 5.2.By Packaging Type
    • 5.2.1.Primary
      • 5.2.1.1.Plastic Bottles
      • 5.2.1.2.Caps and Closures
      • 5.2.1.3.Parenteral Containers
        • 5.2.1.3.1.Syringes
        • 5.2.1.3.2.Vials and Ampoules
        • 5.2.1.3.3.Others
      • 5.2.1.4.Blister Packs
      • 5.2.1.5.Prefillable Inhalers
      • 5.2.1.6.Pouches
      • 5.2.1.7.Medication Tubes
      • 5.2.1.8.Others
    • 5.2.2.Secondary
      • 5.2.2.1.Prescription Containers
      • 5.2.2.2.Pharmaceutical Packaging Accessories
    • 5.2.3.Tertiary
  • 5.3.By Raw Material
    • 5.3.1.Plastic
    • 5.3.2.Metal
    • 5.3.3.Glass
    • 5.3.4.Paper and Paperboards
    • 5.3.5.Others
  • 5.4.By Drug Delivery
    • 5.4.1.Oral Drugs
    • 5.4.2.Topicals
    • 5.4.3.Injectables
    • 5.4.4.Pulmonary
    • 5.4.5.Nasal
    • 5.4.6.Ocular/ Ophthalmic
    • 5.4.7.IV Drugs
    • 5.4.8.Transdermal
    • 5.4.9.Others
  • 5.5.By End-user
    • 5.5.1.Pharmaceutical Manufacturing
    • 5.5.2.Retail Pharmacy
    • 5.5.3.Contract Packaging
    • 5.5.4.Institutional Pharmacy
  • 5.6.By Region
    • 5.6.1.North America
    • 5.6.2.South America
    • 5.6.3.Europe
    • 5.6.4.Asia-Pacific
    • 5.6.5.Middle East & Africa
  • 5.7.By Company Market Share (%), 2023

6.Global Pharma Packaging Materials Market Outlook, By Region, 2017-2031F

  • 6.1.North America*
    • 6.1.1.Market Size & Forecast
      • 6.1.1.1.By Value
      • 6.1.1.2.By Volume
    • 6.1.2.By Packaging Type
      • 6.1.2.1.Primary
        • 6.1.2.1.1.Plastic Bottles
        • 6.1.2.1.2.Caps and Closures
        • 6.1.2.1.3.Parenteral Containers
          • 6.1.2.1.3.1.Syringes
          • 6.1.2.1.3.2.Vials and Ampoules
          • 6.1.2.1.3.3.Others
        • 6.1.2.1.4.Blister Packs
        • 6.1.2.1.5.Prefillable Inhalers
        • 6.1.2.1.6.Pouches
        • 6.1.2.1.7.Medication Tubes
        • 6.1.2.1.8.Others
      • 6.1.2.2.Secondary
        • 6.1.2.2.1.Prescription Containers
        • 6.1.2.2.2.Pharmaceutical Packaging Accessories
      • 6.1.2.3.Tertiary
    • 6.1.3.By Raw Material
      • 6.1.3.1.Plastic
      • 6.1.3.2.Metal
      • 6.1.3.3.Glass
      • 6.1.3.4.Paper and Paperboards
      • 6.1.3.5.Others
    • 6.1.4.By Drug Delivery
      • 6.1.4.1.Oral Drugs
      • 6.1.4.2.Topicals
      • 6.1.4.3.Injectables
      • 6.1.4.4.Pulmonary
      • 6.1.4.5.Nasal
      • 6.1.4.6.Ocular/ Ophthalmic
      • 6.1.4.7.IV Drugs
      • 6.1.4.8.Transdermal
      • 6.1.4.9.Others
    • 6.1.5.By End-user
      • 6.1.5.1.Pharmaceutical Manufacturing
      • 6.1.5.2.Retail Pharmacy
      • 6.1.5.3.Contract Packaging
      • 6.1.5.4.Institutional Pharmacy
    • 6.1.6.United States*
      • 6.1.6.1.Market Size & Forecast
        • 6.1.6.1.1.By Value
        • 6.1.6.1.2.By Volume
      • 6.1.6.2.By Packaging Type
        • 6.1.6.2.1.Primary
          • 6.1.6.2.1.1.Plastic Bottles
          • 6.1.6.2.1.2.Caps and Closures
          • 6.1.6.2.1.3.Parenteral Containers
          • 6.1.6.2.1.3.1.Syringes
          • 6.1.6.2.1.3.2.Vials and Ampoules
          • 6.1.6.2.1.3.3.Others
          • 6.1.6.2.1.4.Blister Packs
          • 6.1.6.2.1.5.Prefillable Inhalers
          • 6.1.6.2.1.6.Pouches
          • 6.1.6.2.1.7.Medication Tubes
          • 6.1.6.2.1.8.Others
        • 6.1.6.2.2.Secondary
          • 6.1.6.2.2.1.Prescription Containers
          • 6.1.6.2.2.2.Pharmaceutical Packaging Accessories
        • 6.1.6.2.3.Tertiary
      • 6.1.6.3.By Raw Material
        • 6.1.6.3.1.Plastic
        • 6.1.6.3.2.Metal
        • 6.1.6.3.3.Glass
        • 6.1.6.3.4.Paper and Paperboards
        • 6.1.6.3.5.Others
      • 6.1.6.4.By Drug Delivery
        • 6.1.6.4.1.Oral Drugs
        • 6.1.6.4.2.Topicals
        • 6.1.6.4.3.Injectables
        • 6.1.6.4.4.Pulmonary
        • 6.1.6.4.5.Nasal
        • 6.1.6.4.6.Ocular/ Ophthalmic
        • 6.1.6.4.7.IV Drugs
        • 6.1.6.4.8.Transdermal
        • 6.1.6.4.9.Others
      • 6.1.6.5.By End-user
        • 6.1.6.5.1.Pharmaceutical Manufacturing
        • 6.1.6.5.2.Retail Pharmacy
        • 6.1.6.5.3.Contract Packaging
        • 6.1.6.5.4.Institutional Pharmacy
    • 6.1.7.Canada
    • 6.1.8.Mexico

All segments will be provided for all regions and countries covered

  • 6.2.Europe
    • 6.2.1.Germany
    • 6.2.2.France
    • 6.2.3.Italy
    • 6.2.4.United Kingdom
    • 6.2.5.Russia
    • 6.2.6.Netherlands
    • 6.2.7.Spain
    • 6.2.8.Turkey
    • 6.2.9.Poland
  • 6.3.Asia-Pacific
    • 6.3.1.India
    • 6.3.2.China
    • 6.3.3.Japan
    • 6.3.4.Australia
    • 6.3.5.Vietnam
    • 6.3.6.South Korea
    • 6.3.7.Indonesia
    • 6.3.8.Philippines
  • 6.4.South America
    • 6.4.1.Brazil
    • 6.4.2.Argentina
  • 6.5.Middle East & Africa
    • 6.5.1.Saudi Arabia
    • 6.5.2.UAE
    • 6.5.3.South Africa

7.Supply Side Analysis

  • 7.1.Capacity, By Company
  • 7.2.Production, By Company
  • 7.3.Operating Efficiency, By Company
  • 7.4.Key Plant Locations (Up to 25)

8.Market Mapping, 2023

  • 8.1.By Packaging Type
  • 8.2.By Raw Material
  • 8.3.By Drug Delivery
  • 8.4.By End-user
  • 8.5.By Region

9.Macro Environment and Industry Structure

  • 9.1.Supply Demand Analysis
  • 9.2.Import Export Analysis
  • 9.3.Supply Chain Analysis
  • 9.4.PESTEL Analysis
    • 9.4.1.Political Factors
    • 9.4.2.Economic System
    • 9.4.3.Social Implications
    • 9.4.4.Technological Advancements
    • 9.4.5.Environmental Impacts
    • 9.4.6.Legal Compliances and Regulatory Policies (Statutory Bodies Included)
  • 9.5.Porter's Five Forces Analysis
    • 9.5.1.Supplier Power
    • 9.5.2.Buyer Power
    • 9.5.3.Substitution Threat
    • 9.5.4.Threat from New Entrant
    • 9.5.5.Competitive Rivalry

10.Market Dynamics

  • 10.1.Growth Drivers
  • 10.2.Growth Inhibitors (Challenges and Restraints)

11.Key Players Landscape

  • 11.1.Competition Matrix of Top Five Market Leaders
  • 11.2.Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
  • 11.3.Mergers and Acquisitions/Joint Ventures (If Applicable)
  • 11.4.SWOT Analysis (For Five Market Players)
  • 11.5.Patent Analysis (If Applicable)

12.Pricing Analysis

13.Case Studies

14.Key Players Outlook

  • 14.1.Amcor plc
    • 14.1.1.Company Details
    • 14.1.2.Key Management Personnel
    • 14.1.3.Products & Services
    • 14.1.4.Financials (As reported)
    • 14.1.5.Key Market Focus & Geographical Presence
    • 14.1.6.Recent Developments
  • 14.2.Berry Global Group, Inc.
  • 14.3.Gerresheimer AG
  • 14.4.Schott AG
  • 14.5.AptarGroup Inc.
  • 14.6.Catalent, Inc.
  • 14.7.WestRock Company
  • 14.8.Becton, Dickinson, and Company
  • 14.9.Nipro Corporation
  • 14.10.CCL Industries Inc.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work

15.Strategic Recommendations

16.About Us & Disclaimer

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1.Global Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
  • Figure 2.Global Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
  • Figure 3.Global Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
  • Figure 4.Global Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
  • Figure 5.Global Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
  • Figure 6.Global Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
  • Figure 7.Global Pharma Packaging Materials Market Share (%), By Region, 2017-2031F
  • Figure 8.North America Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
  • Figure 9.North America Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
  • Figure 10.North America Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
  • Figure 11.North America Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
  • Figure 12.North America Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
  • Figure 13.North America Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
  • Figure 14.North America Pharma Packaging Materials Market Share (%), By Country, 2017-2031F
  • Figure 15.United States Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
  • Figure 16.United States Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
  • Figure 17.United States Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
  • Figure 18.United States Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
  • Figure 19.United States Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
  • Figure 20.United States Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
  • Figure 21.Canada Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
  • Figure 22.Canada Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
  • Figure 23.Canada Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
  • Figure 24.Canada Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
  • Figure 25.Canada Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
  • Figure 26.Canada Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
  • Figure 27.Mexico Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
  • Figure 28.Mexico Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
  • Figure 29.Mexico Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
  • Figure 30.Mexico Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
  • Figure 31.Mexico Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
  • Figure 32.Mexico Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
  • Figure 33.Europe Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
  • Figure 34.Europe Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
  • Figure 35.Europe Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
  • Figure 36.Europe Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
  • Figure 37.Europe Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
  • Figure 38.Europe Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
  • Figure 39.Europe Pharma Packaging Materials Market Share (%), By Country, 2017-2031F
  • Figure 40.Germany Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
  • Figure 41.Germany Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
  • Figure 42.Germany Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
  • Figure 43.Germany Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
  • Figure 44.Germany Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
  • Figure 45.Germany Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
  • Figure 46.France Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
  • Figure 47.France Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
  • Figure 48.France Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
  • Figure 49.France Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
  • Figure 50.France Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
  • Figure 51.France Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
  • Figure 52.Italy Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
  • Figure 53.Italy Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
  • Figure 54.Italy Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
  • Figure 55.Italy Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
  • Figure 56.Italy Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
  • Figure 57.Italy Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
  • Figure 58.United Kingdom Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
  • Figure 59.United Kingdom Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
  • Figure 60.United Kingdom Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
  • Figure 61.United Kingdom Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
  • Figure 62.United Kingdom Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
  • Figure 63.United Kingdom Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
  • Figure 64.Russia Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
  • Figure 65.Russia Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
  • Figure 66.Russia Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
  • Figure 67.Russia Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
  • Figure 68.Russia Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
  • Figure 69.Russia Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
  • Figure 70.Netherlands Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
  • Figure 71.Netherlands Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
  • Figure 72.Netherlands Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
  • Figure 73.Netherlands Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
  • Figure 74.Netherlands Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
  • Figure 75.Netherlands Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
  • Figure 76.Spain Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
  • Figure 77.Spain Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
  • Figure 78.Spain Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
  • Figure 79.Spain Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
  • Figure 80.Spain Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
  • Figure 81.Spain Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
  • Figure 82.Turkey Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
  • Figure 83.Turkey Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
  • Figure 84.Turkey Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
  • Figure 85.Turkey Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
  • Figure 86.Turkey Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
  • Figure 87.Turkey Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
  • Figure 88.Poland Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
  • Figure 89.Poland Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
  • Figure 90.Poland Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
  • Figure 91.Poland Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
  • Figure 92.Poland Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
  • Figure 93.Poland Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
  • Figure 94.South America Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
  • Figure 95.South America Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
  • Figure 96.South America Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
  • Figure 97.South America Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
  • Figure 98.South America Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
  • Figure 99.South America Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
  • Figure 100.South America Pharma Packaging Materials Market Share (%), By Country, 2017-2031F
  • Figure 101.Brazil Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
  • Figure 102.Brazil Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
  • Figure 103.Brazil Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
  • Figure 104.Brazil Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
  • Figure 105.Brazil Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
  • Figure 106.Brazil Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
  • Figure 107.Argentina Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
  • Figure 108.Argentina Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
  • Figure 109.Argentina Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
  • Figure 110.Argentina Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
  • Figure 111.Argentina Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
  • Figure 112.Argentina Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
  • Figure 113.Asia-Pacific Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
  • Figure 114.Asia-Pacific Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
  • Figure 115.Asia-Pacific Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
  • Figure 116.Asia-Pacific Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
  • Figure 117.Asia-Pacific Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
  • Figure 118.Asia-Pacific Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
  • Figure 119.Asia-Pacific Pharma Packaging Materials Market Share (%), By Country, 2017-2031F
  • Figure 120.India Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
  • Figure 121.India Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
  • Figure 122.India Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
  • Figure 123.India Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
  • Figure 124.India Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
  • Figure 125.India Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
  • Figure 126.China Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
  • Figure 127.China Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
  • Figure 128.China Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
  • Figure 129.China Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
  • Figure 130.China Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
  • Figure 131.China Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
  • Figure 132.Japan Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
  • Figure 133.Japan Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
  • Figure 134.Japan Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
  • Figure 135.Japan Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
  • Figure 136.Japan Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
  • Figure 137.Japan Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
  • Figure 138.Australia Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
  • Figure 139.Australia Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
  • Figure 140.Australia Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
  • Figure 141.Australia Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
  • Figure 142.Australia Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
  • Figure 143.Australia Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
  • Figure 144.Vietnam Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
  • Figure 145.Vietnam Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
  • Figure 146.Vietnam Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
  • Figure 147.Vietnam Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
  • Figure 148.Vietnam Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
  • Figure 149.Vietnam Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
  • Figure 150.South Korea Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
  • Figure 151.South Korea Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
  • Figure 152.South Korea Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
  • Figure 153.South Korea Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
  • Figure 154.South Korea Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
  • Figure 155.South Korea Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
  • Figure 156.Indonesia Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
  • Figure 157.Indonesia Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
  • Figure 158.Indonesia Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
  • Figure 159.Indonesia Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
  • Figure 160.Indonesia Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
  • Figure 161.Indonesia Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
  • Figure 162.Philippines Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
  • Figure 163.Philippines Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
  • Figure 164.Philippines Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
  • Figure 165.Philippines Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
  • Figure 166.Philippines Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
  • Figure 167.Philippines Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
  • Figure 168.Middle East & Africa Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
  • Figure 169.Middle East & Africa Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
  • Figure 170.Middle East & Africa Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
  • Figure 171.Middle East & Africa Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
  • Figure 172.Middle East & Africa Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
  • Figure 173.Middle East & Africa Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
  • Figure 174.Middle East & Africa Pharma Packaging Materials Market Share (%), By Country, 2017-2031F
  • Figure 175.Saudi Arabia Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
  • Figure 176.Saudi Arabia Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
  • Figure 177.Saudi Arabia Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
  • Figure 178.Saudi Arabia Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
  • Figure 179.Saudi Arabia Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
  • Figure 180.Saudi Arabia Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
  • Figure 181.UAE Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
  • Figure 182.UAE Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
  • Figure 183.UAE Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
  • Figure 184.UAE Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
  • Figure 185.UAE Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
  • Figure 186.UAE Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
  • Figure 187.South Africa Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
  • Figure 188.South Africa Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
  • Figure 189.South Africa Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
  • Figure 190.South Africa Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
  • Figure 191.South Africa Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
  • Figure 192.South Africa Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
  • Figure 193.By Packaging Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 194.By Raw Material Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 195.By Drug Delivery Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 196.By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 197.By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023